Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript May 11, 2023
Marinus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.67, expectations were $-0.72.
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. And now it is my pleasure to...
